Drug Approval | November 29, 2025
Innoxel Lifesciences completes EU GMP inspection by Belgium's FAMHP
The audit was completed with zero critical and zero major observations
The audit was completed with zero critical and zero major observations
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
The fresh capital will propel Cordance into its first-in-human clinical trial
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Subscribe To Our Newsletter & Stay Updated
